My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a big responsibility for a small child to carry an injector loaded with lifesaving epinephrine, but ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

First generic version of Epinephrine 1mg/1mL vial in U.S. market LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, ...

If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...

RESEARCH TRIANGLE PARK – Millions of Americans are at risk for anaphylaxis, a severe allergic reaction to medicines, foods, bee stings, insect bites, dust, latex or other substances. And up to 25% of ...

The MarketWatch News Department was not involved in the creation of this content. 34-member international panel led by experts at Cincinnati Children's offers first consensus guidelines that seek to ...

Medically reviewed by Jurairat J. Molina, MD Key Takeaways Milk allergy can cause serious reactions like anaphylaxis and ...

Please provide your email address to receive an email when new articles are posted on . Intranasal spray had faster and higher maximum concentrations than autoinjectors and manual syringes. The spray ...

ORLANDO -- Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists' office. "I was pretty shocked the first time I used it ...

WASHINGTON -- Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of resolved allergic symptoms in children and ...

SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves ...

Kaléo, a small drugmaker and EpiPen rival, has been acquired by Marathon Asset Management in a deal valued at $310 million. The funding is expected to fuel the company’s growth in the allergy ...